| PDF (646kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-305280
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.30528
Zusammenfassung
The most frequent mature aggressive B-cell lymphomas are diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL). Patients suffering from molecularly defined BL (mBL) but treated with a regimen developed for DLBCL show an unfavorable outcome compared with mBL treated with chemotherapy regimens for BL. Distinguishing BL from DLBCL by conventional histopathology is challenging in lymphomas ...
![plus plus](/style/images/plus.png)
Nur für Besitzer und Autoren: Kontrollseite des Eintrags